Apellis Pharmaceuticals, Inc. APLS
41.03 USD 0.00 (+0.00%)
At closeMay 15, 2026, 4:00 PM EDT
41.06 +0.03 +0.07%
After hours · May 15, 4:00 PM ET
41.03 Day range 41.05
52-week range unavailable
- YTD
- +63.34%
- 1 year
- +150.79%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.00B | 781.37M | 396.59M | 75.42M | 66.56M | |
| 1.00B | 781.37M | 396.59M | 75.42M | 66.56M | |
| 102.24M | 117.72M | 58.51M | 5.64M | 200.00K | |
| 901.55M | 663.64M | 338.08M | 69.79M | 66.36M | |
| 846.12M | 828.62M | 855.20M | 664.40M | 602.64M | |
| 295.85M | 327.57M | 354.39M | 387.24M | 345.87M | |
| 550.26M | 501.05M | 500.81M | 277.16M | 176.77M | |
| 55.43M | -164.98M | -517.12M | -594.61M | -536.28M | |
| 44.33M | 40.39M | 29.58M | 32.63M | 13.24M | |
| 1.72M | 1.16M | 2.13M | 669.00K | 352.00K | |
| 22.39M | -197.88M | -528.63M | -652.17M | -746.35M | |
| 22.39M | -197.88M | -528.63M | -652.17M | -746.35M | |
| 22.39M | -197.88M | -528.63M | -652.17M | -746.35M | |
| 22.39M | -197.88M | -528.63M | -652.17M | -746.35M | |
| 0.18 | -1.60 | -4.45 | -6.15 | -8.84 | |
| 0.18 | -1.60 | -4.45 | -6.15 | -8.84 | |
| 0.20 | -1.60 | -4.45 | -6.15 | -8.84 | |
| 68.44M | -156.32M | -496.92M | -618.88M | -732.76M | |
| 68.44M | -156.32M | -496.92M | -618.88M | -732.76M | |
| 126.14M | 123.91M | 118.68M | 106.11M | 84.42M | |
| 129.85M | 123.91M | 118.68M | 106.11M | 84.42M |